Biolex files for $70 mln IPO

Aug 14 (Reuters) - Clinical-stage biopharmaceutical company Biolex Inc. said it filed with U.S. regulators to raise up to $70 million in an initial public offering of common stock. The Pittsboro, North Carolina-based company said it applied for listing on the Nasdaq under the symbol "BLEX".

Lehman Brothers Inc. and Deutsche Bank Securities Inc. are acting as joint book-running managers, Biolex added. (Reporting by Esha Dey in Bangalore)